{
    "analytics_identifier":  null,
    "base_path":  "/guidance/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19",
    "content_id":  "03ea9063-5ac9-4f59-ab95-661d0fbbfbb6",
    "description":  "Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19",
    "details":  {
                    "attachments":  [
                                        {
                                            "accessible":  false,
                                            "alternative_format_contact_email":  "webupdates@mhra.gov.uk",
                                            "attachment_type":  "file",
                                            "content_type":  "application/pdf",
                                            "file_size":  369654,
                                            "filename":  "thalid-PPPs_COVID-19_DHPC.pdf",
                                            "id":  "4221932",
                                            "number_of_pages":  3,
                                            "title":  "letter to healthcare professionals ",
                                            "url":  "https://assets.publishing.service.gov.uk/media/5ec66192d3bf7f45fdcf684e/thalid-PPPs_COVID-19_DHPC.pdf"
                                        }
                                    ],
                    "body":  "\u003cdiv class=\"govspeak\"\u003e\u003cp\u003eWe have agreed for temporary modifications to be made to the pregnancy prevention programmes for these medicines to facilitate home pregnancy testing and remote consultations, where clinically appropriate, during the COVID-19 pandemic.\u003c/p\u003e\n\n\u003ch2 id=\"pregnancy-prevention-with-immunomodulatory-drugs\"\u003ePregnancy prevention with immunomodulatory drugs\u003c/h2\u003e\n\n\u003cp\u003eThalidomide (Thalidomide Celgene), lenalidomide (Revlimid), and pomalidomide (Imnovid) are immunomodulatory drugs that are used in some patients with multiple myeloma. Lenalidomide is also used for some other blood cancers or disorders (lymphoma and myelodysplastic syndromes).\u003c/p\u003e\n\n\u003cp\u003eAll 3 medicines are teratogenic, which means they can cause severe birth defects, and must be used within a pregnancy prevention programme. This is a programme designed to make sure that unborn babies are not exposed to these medicines.\u003c/p\u003e\n\n\u003cp\u003eTo enable the shielding of patients who are receiving these medicines during the COVID-19 pandemic, the manufacturer (Celgene) has issued a \u003cspan class=\"gem-c-attachment-link\"\u003e\n  \u003ca class=\"govuk-link\" href=\"https://assets.publishing.service.gov.uk/media/5ec66192d3bf7f45fdcf684e/thalid-PPPs_COVID-19_DHPC.pdf\"\u003eletter to healthcare professionals \u003c/a\u003e  (\u003cspan class=\"gem-c-attachment-link__attribute\"\u003e\u003cabbr title=\"Portable Document Format\" class=\"gem-c-attachment-link__abbr\"\u003ePDF\u003c/abbr\u003e\u003c/span\u003e, \u003cspan class=\"gem-c-attachment-link__attribute\"\u003e361 KB\u003c/span\u003e, \u003cspan class=\"gem-c-attachment-link__attribute\"\u003e3 pages\u003c/span\u003e)\u003c/span\u003e informing them of temporary modifications to the pregnancy prevention programmes to facilitate home pregnancy testing and remote consultations, where clinically appropriate.\u003c/p\u003e\n\n\u003cp\u003eThese temporary modifications have been agreed with the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e until the recommended shielding measures have been lifted.\u003c/p\u003e\n\n\u003ch2 id=\"home-pregnancy-testing\"\u003eHome pregnancy testing\u003c/h2\u003e\n\n\u003cp\u003eAs part of the Pregnancy Prevention Programmes for thalidomide, lenalidomide, and pomalidomide, a medically supervised pregnancy test (minimum sensitivity of 25mlU/mL) must be performed for women of childbearing potential:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003ebefore starting treatment\u003c/li\u003e\n  \u003cli\u003eat least every 4 weeks during treatment\u003c/li\u003e\n  \u003cli\u003eat least 4 weeks after finishing treatment\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eWhilst shielding measures are in place, pregnancy testing by the patient at home is acceptable, at the discretion of the clinician, provided the following minimum criteria are met:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eadequate instruction and support are provided\u003c/li\u003e\n  \u003cli\u003ethe pregnancy tests meet the minimum required sensitivity (25mIU/mL)\u003c/li\u003e\n  \u003cli\u003ethe result of each pregnancy test is verified by the prescriber\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eFor prescriber verification, ideally the patient should send a photograph of the test result by email/video conferencing. If no email or video conferencing is available, then a telephone description of the test result, kit make, and how it was used would be a minimum requirement.\u003c/p\u003e\n\n\u003cp\u003eFurther details on these criteria are provided in the letter to healthcare professionals.\u003c/p\u003e\n\n\u003ch2 id=\"remote-consultation\"\u003eRemote consultation\u003c/h2\u003e\n\n\u003cp\u003eBefore starting treatment with thalidomide, lenalidomide, and pomalidomide, the patient and prescriber must sign a Treatment Initiation Form (\u003cabbr title=\"Treatment Initiation Form\"\u003eTIF\u003c/abbr\u003e). This form documents that they both agree to the conditions of the pregnancy prevention programme.\u003c/p\u003e\n\n\u003cp\u003eDuring treatment, a Prescription Authorisation Form (\u003cabbr title=\"Prescription Authorisation Form\"\u003ePAF\u003c/abbr\u003e), which is completed by the prescriber and dispensing pharmacist, must accompany each prescription of thalidomide, lenalidomide, and pomalidomide. This form documents that the patient understands the risk of teratogenicity and continues to take pregnancy prevention measures, if required. A completed \u003cabbr title=\"Prescription Authorisation Form\"\u003ePAF\u003c/abbr\u003e is required for a prescription to be dispensed.\u003c/p\u003e\n\n\u003cp\u003eWhere the clinician determines that a remote consultation is clinically appropriate for a patient whilst shielding measures are in place, electronic editable versions of the TIFs and paper PAFs have been made available via the registered Chief Pharmacist (or their Deputy). Prescribers should contact their pharmacists to obtain access to these forms should they be required.\u003c/p\u003e\n\n\u003cp\u003eThe electronic version of the paper \u003cabbr title=\"Prescription Authorisation Form\"\u003ePAF\u003c/abbr\u003e allows the prescriber to complete the form and send to the pharmacist electronically, who can then dispense the prescription.\u003c/p\u003e\n\n\u003cp\u003eIf the clinician decides that a remote consultation is an appropriate environment for initiating treatment with these medicines, they must consider how they will adequately meet the requirement to educate patients and undertake the required clinical review and baseline assessment.\u003c/p\u003e\n\n\u003cp\u003eThe Summary of Product Characteristics (\u003cabbr title=\"Summary of Product Characteristics\"\u003eSmPCs\u003c/abbr\u003e) of these medicines should be consulted to help ensure safe and effective use, including the requirement to monitor for cytopenias (a decrease in blood cells).\u003c/p\u003e\n\n\u003cp\u003eSee the \u003ca href=\"https://www.gov.uk/guidance/find-product-information-about-medicines\" class=\"govuk-link\"\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e Products website\u003c/a\u003e for the information about these medicines, including for the \u003cabbr title=\"Summary of Product Characteristics\"\u003eSmPCs\u003c/abbr\u003e and patient information leaflets (\u003cabbr title=\"patient information leaflets\"\u003ePILs\u003c/abbr\u003e).\u003c/p\u003e\n\n\u003cp\u003eIn addition, the patient must still receive an educational booklet and a hard copy of the \u003cabbr title=\"Treatment Initiation Form\"\u003eTIF\u003c/abbr\u003e to read, complete and sign before they start treatment, as would be the case in a face-to-face consultation, and send the completed \u003cabbr title=\"Treatment Initiation Form\"\u003eTIF\u003c/abbr\u003e back to the prescriber. This will help ensure that patients are fully informed about the risks of treatment (especially teratogenicity) and the required actions they should take to minimise these risks.\u003c/p\u003e\n\n\u003ch2 id=\"report-any-side-effects-to-the-yellow-card-scheme\"\u003eReport any side effects to the Yellow Card scheme\u003c/h2\u003e\n\n\u003cp\u003eHealthcare professionals, patients, and caregivers are asked to continue to report suspected side effects using the Yellow Card scheme.\u003c/p\u003e\n\n\u003cp\u003ePlease report to the Yellow Card scheme electronically using:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\u003ca rel=\"external\" href=\"https://yellowcard.mhra.gov.uk/\" class=\"govuk-link\"\u003ethe Yellow Card website\u003c/a\u003e\u003c/li\u003e\n  \u003cli\u003ethe Yellow Card app; download now from the \u003ca rel=\"external\" href=\"https://itunes.apple.com/us/app/apple-store/id990237487?pt=117756671\u0026amp;ct=EYC\u0026amp;mt=8\" class=\"govuk-link\"\u003eApple App Store\u003c/a\u003e or \u003ca rel=\"external\" href=\"https://play.google.com/store/apps/details?id=uk.org.mhra.yellowcard\u0026amp;referrer=utm_source%3DEYC%26utm_medium%3Dcpc%26anid%3Dadmob\" class=\"govuk-link\"\u003eGoogle Play Store\u003c/a\u003e\n\u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003ethrough some clinical IT systems (EMIS/SystmOne/Vision/MiDatabank)\u003c/p\u003e\n\n  \u003c/li\u003e\n\u003c/ul\u003e\n\u003c/div\u003e",
                    "change_history":  [
                                           {
                                               "note":  "First published.",
                                               "public_timestamp":  "2020-05-21T12:16:00.000+01:00"
                                           }
                                       ],
                    "emphasised_organisations":  [
                                                     "240f72bd-9a4d-4f39-94d9-77235cadde8e"
                                                 ],
                    "first_public_at":  "2020-05-21T12:16:00.000+01:00",
                    "political":  false,
                    "related_mainstream_content":  [

                                                   ],
                    "tags":  {
                                 "browse_pages":  [

                                                  ]
                             }
                },
    "document_type":  "detailed_guide",
    "first_published_at":  "2020-05-21T12:16:00+01:00",
    "links":  {
                  "available_translations":  [
                                                 {
                                                     "api_path":  "/api/content/guidance/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19",
                                                     "api_url":  "https://www.gov.uk/api/content/guidance/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19",
                                                     "base_path":  "/guidance/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19",
                                                     "content_id":  "03ea9063-5ac9-4f59-ab95-661d0fbbfbb6",
                                                     "document_type":  "detailed_guide",
                                                     "links":  {

                                                               },
                                                     "locale":  "en",
                                                     "public_updated_at":  "2020-05-21T11:16:00Z",
                                                     "schema_name":  "detailed_guide",
                                                     "title":  "Immunomodulatory drugs: temporary pregnancy prevention guidance during coronavirus (COVID-19)",
                                                     "web_url":  "https://www.gov.uk/guidance/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19",
                                                     "withdrawn":  false
                                                 }
                                             ],
                  "document_collections":  [
                                               {
                                                   "api_path":  "/api/content/government/collections/mhra-guidance-on-coronavirus-covid-19",
                                                   "api_url":  "https://www.gov.uk/api/content/government/collections/mhra-guidance-on-coronavirus-covid-19",
                                                   "base_path":  "/government/collections/mhra-guidance-on-coronavirus-covid-19",
                                                   "content_id":  "bc387ef4-b548-4bd4-b355-be562105e1bd",
                                                   "document_type":  "document_collection",
                                                   "links":  {
                                                                 "documents":  [
                                                                                   {
                                                                                       "api_path":  "/api/content/guidance/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19",
                                                                                       "api_url":  "https://www.gov.uk/api/content/guidance/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19",
                                                                                       "base_path":  "/guidance/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19",
                                                                                       "content_id":  "03ea9063-5ac9-4f59-ab95-661d0fbbfbb6",
                                                                                       "document_type":  "detailed_guide",
                                                                                       "links":  {

                                                                                                 },
                                                                                       "locale":  "en",
                                                                                       "public_updated_at":  "2020-05-21T11:16:00Z",
                                                                                       "schema_name":  "detailed_guide",
                                                                                       "title":  "Immunomodulatory drugs: temporary pregnancy prevention guidance during coronavirus (COVID-19)",
                                                                                       "web_url":  "https://www.gov.uk/guidance/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19",
                                                                                       "withdrawn":  false
                                                                                   }
                                                                               ]
                                                             },
                                                   "locale":  "en",
                                                   "public_updated_at":  "2022-06-24T14:38:58Z",
                                                   "schema_name":  "document_collection",
                                                   "title":  "MHRA guidance on coronavirus (COVID-19)",
                                                   "web_url":  "https://www.gov.uk/government/collections/mhra-guidance-on-coronavirus-covid-19",
                                                   "withdrawn":  false
                                               }
                                           ],
                  "government":  [
                                     {
                                         "api_path":  "/api/content/government/2015-conservative-government",
                                         "api_url":  "https://www.gov.uk/api/content/government/2015-conservative-government",
                                         "base_path":  "/government/2015-conservative-government",
                                         "content_id":  "d4fbc1b9-d47d-4386-af04-ac909f868f92",
                                         "details":  {
                                                         "current":  false,
                                                         "ended_on":  "2016-07-13T00:00:00+00:00",
                                                         "started_on":  "2015-05-08T00:00:00+00:00"
                                                     },
                                         "document_type":  "government",
                                         "links":  {

                                                   },
                                         "locale":  "en",
                                         "title":  "2015 to 2016 Cameron Conservative government",
                                         "web_url":  "https://www.gov.uk/government/2015-conservative-government"
                                     }
                                 ],
                  "organisations":  [
                                        {
                                            "analytics_identifier":  "EA63",
                                            "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                            "details":  {
                                                            "acronym":  "MHRA",
                                                            "brand":  "department-of-health",
                                                            "default_news_image":  null,
                                                            "logo":  {
                                                                         "crest":  "single-identity",
                                                                         "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                     },
                                                            "organisation_govuk_status":  {
                                                                                              "status":  "live",
                                                                                              "updated_at":  null,
                                                                                              "url":  null
                                                                                          }
                                                        },
                                            "document_type":  "organisation",
                                            "links":  {

                                                      },
                                            "locale":  "en",
                                            "schema_name":  "organisation",
                                            "title":  "Medicines and Healthcare products Regulatory Agency",
                                            "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "withdrawn":  false
                                        }
                                    ],
                  "original_primary_publishing_organisation":  [
                                                                   {
                                                                       "analytics_identifier":  "EA63",
                                                                       "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                                       "details":  {
                                                                                       "acronym":  "MHRA",
                                                                                       "brand":  "department-of-health",
                                                                                       "default_news_image":  null,
                                                                                       "logo":  {
                                                                                                    "crest":  "single-identity",
                                                                                                    "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                                },
                                                                                       "organisation_govuk_status":  {
                                                                                                                         "status":  "live",
                                                                                                                         "updated_at":  null,
                                                                                                                         "url":  null
                                                                                                                     }
                                                                                   },
                                                                       "document_type":  "organisation",
                                                                       "links":  {

                                                                                 },
                                                                       "locale":  "en",
                                                                       "schema_name":  "organisation",
                                                                       "title":  "Medicines and Healthcare products Regulatory Agency",
                                                                       "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "withdrawn":  false
                                                                   }
                                                               ],
                  "primary_publishing_organisation":  [
                                                          {
                                                              "analytics_identifier":  "EA63",
                                                              "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                              "details":  {
                                                                              "acronym":  "MHRA",
                                                                              "brand":  "department-of-health",
                                                                              "default_news_image":  null,
                                                                              "logo":  {
                                                                                           "crest":  "single-identity",
                                                                                           "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                       },
                                                                              "organisation_govuk_status":  {
                                                                                                                "status":  "live",
                                                                                                                "updated_at":  null,
                                                                                                                "url":  null
                                                                                                            }
                                                                          },
                                                              "document_type":  "organisation",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "schema_name":  "organisation",
                                                              "title":  "Medicines and Healthcare products Regulatory Agency",
                                                              "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "suggested_ordered_related_items":  [
                                                          {
                                                              "api_path":  "/api/content/guidance/safety-public-assessment-reports",
                                                              "api_url":  "https://www.gov.uk/api/content/guidance/safety-public-assessment-reports",
                                                              "base_path":  "/guidance/safety-public-assessment-reports",
                                                              "content_id":  "7f3adf55-23a7-4af7-bf77-3da7afbb248e",
                                                              "document_type":  "detailed_guide",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2024-09-05T13:33:03Z",
                                                              "schema_name":  "detailed_guide",
                                                              "title":  "Safety Public Assessment Reports",
                                                              "web_url":  "https://www.gov.uk/guidance/safety-public-assessment-reports",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "taxons":  [
                                 {
                                     "api_path":  "/api/content/coronavirus-taxon/health-and-wellbeing",
                                     "api_url":  "https://www.gov.uk/api/content/coronavirus-taxon/health-and-wellbeing",
                                     "base_path":  "/coronavirus-taxon/health-and-wellbeing",
                                     "content_id":  "0f3357e6-23ae-4ad2-9d31-a55a72cbb227",
                                     "description":  "",
                                     "details":  {
                                                     "internal_name":  "Health and wellbeing during COVID-19",
                                                     "notes_for_editors":  "",
                                                     "url_override":  "",
                                                     "visible_to_departmental_editors":  false
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/coronavirus-taxon",
                                                                             "api_url":  "https://www.gov.uk/api/content/coronavirus-taxon",
                                                                             "base_path":  "/coronavirus-taxon",
                                                                             "content_id":  "5b7b9532-a775-4bd2-a3aa-6ce380184b6c",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "COVID-19",
                                                                                             "notes_for_editors":  "",
                                                                                             "url_override":  "",
                                                                                             "visible_to_departmental_editors":  true
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "root_taxon":  [
                                                                                                              {
                                                                                                                  "api_path":  "/api/content/",
                                                                                                                  "api_url":  "https://www.gov.uk/api/content/",
                                                                                                                  "base_path":  "/",
                                                                                                                  "content_id":  "f3bbdec2-0e62-4520-a7fd-6ffd5d36e03a",
                                                                                                                  "document_type":  "homepage",
                                                                                                                  "links":  {

                                                                                                                            },
                                                                                                                  "locale":  "en",
                                                                                                                  "public_updated_at":  "2023-06-28T09:32:34Z",
                                                                                                                  "schema_name":  "homepage",
                                                                                                                  "title":  "GOV.UK homepage",
                                                                                                                  "web_url":  "https://www.gov.uk/",
                                                                                                                  "withdrawn":  false
                                                                                                              }
                                                                                                          ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2023-06-05T09:53:55Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "COVID-19",
                                                                             "web_url":  "https://www.gov.uk/coronavirus-taxon",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2023-06-05T12:37:47Z",
                                     "schema_name":  "taxon",
                                     "title":  "Health and wellbeing during COVID-19",
                                     "web_url":  "https://www.gov.uk/coronavirus-taxon/health-and-wellbeing",
                                     "withdrawn":  false
                                 }
                             ]
              },
    "locale":  "en",
    "phase":  "live",
    "public_updated_at":  "2020-05-21T12:16:00+01:00",
    "publishing_app":  "whitehall",
    "publishing_request_id":  "21-1713893573.652-10.13.28.206-628",
    "publishing_scheduled_at":  null,
    "rendering_app":  "government-frontend",
    "scheduled_publishing_delay_seconds":  null,
    "schema_name":  "detailed_guide",
    "title":  "Immunomodulatory drugs: temporary pregnancy prevention guidance during coronavirus (COVID-19)",
    "updated_at":  "2024-10-22T13:10:37+01:00",
    "withdrawn_notice":  {

                         }
}
